このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Person-centred eHealth for Treatment and Rehabilitation of Severe Stress and Burnout Syndrome (PROMISE)

2020年8月26日 更新者:Göteborg University

Person-centred eHealth for Treatment and Rehabilitation of Severe Stress and Burnout Syndrome - a Randomized Controlled Trial in Primary Health Care

The goal of the research project PROMISE is to translate the person-centred care (PCC) principles into an eHealth (the use of information and communication technologies for health) context. A developed PCC eHealth platform will be used as a tool to identify patients´ resources to enhance coping and living with their illness by means of a dialog and partnership with staff and relatives. The PCC eHealth platform will not replace, but instead be used as add on treatment to usual care (guideline directed care).

調査の概要

詳細な説明

A pilot study and collaboration between patients, relatives and professionals in the research program has clarified the need to develop a PCC eHealth platform. Previous research has shown that eHealth support, where the users are not involved in the process, has a low impact and has highlighted several limitations with respect to: patients' participation in the design process; its anchorage in the home and local environment and opportunities for communication rather than information. Therefore this study has a participatory design which assumes that all users (patients, relatives and health care professionals) are involved in the study design which facilitates implementation. An end-user perspective as a starting point increases the chances that users adapt a positive attitude towards the new system. Person-centred care combined with an eHealth support along the chain of health care showed a 4-fold chance of improved self-efficacy in combination with return to work or prior activity level after an event of acute coronary syndrome.

The aim of this project is that PCC can be delivered at distance and make health care more effective above and beyond usual care. Inclusion of the principles of PCC in an eHealth support for patients with stress, depression or anxiety will improve return to work rates, reduced relapse, reduce costs and improved self-efficacy.

In the PCC approach, the aims, capabilities and needs of each patient, will be the starting point. Self-care strategies will be reinforced and empowered.

This study is a randomized, open, parallel group intervention study where patients are eligible when they start their sick leave period due to stress, depression or anxiety. They will be asked about participation after being diagnosed and their sick leave has been approved.

Patients will be randomized into either the control or the intervention arm 1:1. The control group will receive usual care. The intervention group will receive usual care plus a PCC intervention through an eHealth platform. Randomization will be done through computer generated lists and stored in sealed envelopes.

Patients listed in primary care with a confirmed diagnosis of stress, depression or anxiety will be screened and sent an informing letter about the study from the chief at each centre. Specially trained registered nurses (RNs) will then screen patients against study inclusion and exclusion criteria and by phone contact eligible patients and inform the patient about the aims of the study and ask if they are interested to participate. If the patient wants to participate a consent form is sent to the patient and then returned to the RN. Written informed consent will then be obtained. Then the randomization procedure is performed which is stratified for age (≥ 50y) and diagnosis (stress, depression and anxiety) and the patient will be informed about the outcome by phone. Patients randomized to the intervention group will need a computer, smart phone or iPad to participate in the study.

Two dedicated full-time RNs follow the procedures closely. A monitor controls the protocol adherence. All case record forms, questionnaires and referrals will be constructed (for intervention and usual care groups).

Follow-up questionnaires on general self-efficacy, self-efficacy (self-care) quality of life, anxiety and depression, symptom burden and daily functional level will be sent out to all patients in both groups after 3,6,12,18 and 24 months after randomization.

Patients randomized to usual care will be managed by regular evidence-based treatment and care as outlined in treatment guidelines and followed as usual at their local primary care centre.

Patients will be contacted by a RN who has received special training in PCC communication at distance through the eHealth platform, for an initial person-centred dialogue by phone. Based on the patient narrative patient´s goals, resources and needs are identified. The patient (sometimes maybe together with relatives) and the RN formulate a person-centred health plan. This plan is part of and will be up-loaded to the eHealth platform which also contains individual notes and information about stress, depression and anxiety. The plan will be the point of departure for the forthcoming dialogue at distance via the eHealth platform that the patient and the RN will have during the study period (6 months).

The eHealth support contains headings that may inspire the patient to make notes on "a good day" respectively "a bad day" and register daily health related status. The health plan contain three parts; 1. "My goal is to feel or be able to do". 2. "To be able to reach my goal I will." 3."Support I need to reach my goal". In the communication during the study period between the RN and patient, the personal health plan is discussed and any needs of reformulating the goals may be discussed. The overall goal is to help the patient to identify their own capabilities/resources such as a strong will, social relations etc. and formulate goals that help them increase their self-efficacy and to cope with their condition in daily life.

The RN presents the eHealth support for communication (computer, iPad, smart phone) and they agree on how they will be in contact thereafter. The RN invites the patient and activates their account where he/she can login via an individual user name and formulate, comment, evaluate or develop the health plan. Access to the diary will be password protected. The RN can see the patient´s account and make comments. The patient can add or delete staff or private persons that have access to the account, and the patient can also limit the access for each user invited.

研究の種類

介入

入学 (予想される)

220

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~65年 (大人、高齢者)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

説明

Inclusion Criteria:

• Men and women fulfilling criteria for any of the following diagnoses: stress, depression or anxiety and on sick leave since ≤30 days

• Paid professional work, at least part time, during the last 9 months and willing to participate

Exclusion Criteria:

  • Sick leave >14 days for any of the above mentioned diagnoses during the last 3 months.
  • Severe impairment that prevents patient from using the eHealth support
  • No registered address
  • Not willing to participate
  • Any severe disease with an expected survival <12 months
  • Cognitive impairment
  • Ongoing documented diagnosis of alcohol or drug abuse
  • Other severe disease that can interfere with follow-up or if the intervention is assessed as a burden
  • Patient participating in another conflicting randomized study

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 主な目的:支持療法
  • 割り当て:ランダム化
  • 介入モデル:並列代入
  • マスキング:なし(オープンラベル)

武器と介入

参加者グループ / アーム
介入・治療
介入なし:普段のお手入れ
科学的根拠に基づいたケア
実験的:Person-centred care at distance
Person-centred care at distance through an eHealth platform
専門家、患者、家族が使用する eHealth プラットフォームを介した遠隔地での人中心のケア

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Composite score of changes
時間枠:baseline, 3, 6, 12, 18, 24 months

A patient is classified as improved, deteriorated or unchanged:

A patient is classified as improved if:

at 6 months reduced sick leave and increased general self-efficacy by ≥ 5 units

A patient is classified as deteriorated if:

at 6 months increased sick leave or (if on full-time sick leave at inclusion reduced general self-efficacy by ≥ 5 units)

Those who have neither deteriorated nor improved are considered unchanged

baseline, 3, 6, 12, 18, 24 months

二次結果の測定

結果測定
メジャーの説明
時間枠
Sick leave
時間枠:baseline, 3, 6, 12, 18, 24 months
Grade of sick leave
baseline, 3, 6, 12, 18, 24 months
General self-efficacy scale
時間枠:baseline, 3, 6, 12, 18, 24 months
Questionnaire
baseline, 3, 6, 12, 18, 24 months
Health-related quality of Life (EQ-5D)
時間枠:baseline, 3, 6, 12, 18, 24 months
Questionnaire
baseline, 3, 6, 12, 18, 24 months
Hospital anxiety and depression scale (HADS)
時間枠:baseline, 3, 6, 12, 18, 24 months
Questionnaire
baseline, 3, 6, 12, 18, 24 months
Symptom burden (Shirom-Melamed Burnout Measure)
時間枠:baseline, 3, 6, 12, 18, 24 months
Questionnaire
baseline, 3, 6, 12, 18, 24 months
Perceived stress scale (PSS)
時間枠:baseline, 3, 6, 12, 18, 24 months
Questionnaire
baseline, 3, 6, 12, 18, 24 months
Self-rated burnout syndrome (s-UMS)
時間枠:baseline, 3, 6, 12, 18, 24 months
Questionnaire
baseline, 3, 6, 12, 18, 24 months
Health care utilization
時間枠:3, 6, 12, 18, 24 months
Health care utilization
3, 6, 12, 18, 24 months
Incremental cost-utility ratios
時間枠:3, 6, 12, 18, 24 months
Incremental cost-utility ratios
3, 6, 12, 18, 24 months
Multidimensional fatigue symptom inventory (MFI-20)
時間枠:3, 6, 12, 18, 24 months
Questionnaire
3, 6, 12, 18, 24 months
Sheehan disability scale (SDS)
時間枠:3, 6, 12, 18, 24 months
Questionnaire
3, 6, 12, 18, 24 months
Self-efficacy (self-care)
時間枠:3, 6, 12, 18, 24 months
Questionnaire
3, 6, 12, 18, 24 months

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

捜査官

  • 主任研究者:Andreas Fors, PhD、Institute of health and care sciences, Centre for person-centred care (GPCC)

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (実際)

2018年2月14日

一次修了 (予想される)

2021年1月31日

研究の完了 (予想される)

2022年6月30日

試験登録日

最初に提出

2018年1月12日

QC基準を満たした最初の提出物

2018年1月12日

最初の投稿 (実際)

2018年1月19日

学習記録の更新

投稿された最後の更新 (実際)

2020年8月27日

QC基準を満たした最後の更新が送信されました

2020年8月26日

最終確認日

2020年8月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • PROMISE

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

いいえ

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

メンタルヘルスの臨床試験

購読する